Wegovy was manufactured out there in Europe’s most obese nation on Sept. 4, in what Novo called a “controlled and constrained start”. The Norwegian Medicines Agency claimed in January 2023 it would not subsidise the drug, expressing the price could be much too large in relation into the documented overall https://richardv692mtz4.wikijournalist.com/user